ACIDE CARGLUMIQUE TILLOMED 200 mg, dispersible tablet scored 60 tablets
Active ingredients: Carglumic acid
Commercialized according to BDPMDispensing in France: Prescription only
Dispersible tablet scored60 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ACIDE CARGLUMIQUE TILLOMED 200 mg, comprimé dispersible sécable
- Pharmaceutical form
- comprimé dispersible sécable
- Route of administration
- orale
- Presentation description
- 60 plaquettes prédécoupées unitaires aluminium OPA : polyamide orienté PVC de 1 comprimé
- Marketing authorisation holder
- TILLOMED PHARMA (ALLEMAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 17 Apr 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68569606CIP75509484CIP133400955094845Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACIDE CARGLUMIQUEcomprimé | 200 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.